Gastric Ultrasound for Surgery Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of different fasting protocols before surgery using gastric ultrasound, a non-invasive imaging technique. The researchers will measure the remaining stomach contents in critically ill patients to determine the better fasting approach. Participants will either follow the standard no-food protocol from midnight or a more flexible feeding schedule until right before surgery. Ideal candidates are ICU patients with a breathing tube already in place who require general anesthesia for a procedure. As an unphased trial, this study allows patients to contribute to important research that could enhance pre-surgery fasting protocols.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that gastric ultrasound is safe for surgery patients?
Research has shown that gastric ultrasound is a safe tool for surgery patients. Studies have found it helps doctors check the stomach's contents without invasive procedures. This allows them to determine if a patient has food in their stomach, helping to prevent issues like aspiration (when food or liquid accidentally enters the lungs).
The procedure is non-invasive, involving no cutting or entering the body. No reports of serious side effects have emerged from using gastric ultrasound. Patients generally tolerate it well, and it can enhance safety by aiding doctors in making better pre-surgery decisions.
In summary, gastric ultrasound is a safe method for checking stomach contents in surgery patients.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative protocols for managing pre-surgery fasting, aiming to improve patient outcomes. Traditional protocols require patients to fast from midnight before surgery to reduce the risk of aspiration. This trial compares the standard NPO (nil per os) protocol with a liberal feeding protocol, where patients are fed until they are called to the operating room, using a gastric ultrasound to ensure stomach contents are minimal. This approach could enhance patient comfort and nutrition without increasing surgical risks, offering a potentially transformative shift in preoperative care.
What evidence suggests that gastric ultrasound is effective for quantifying gastric residual volumes in critically ill patients?
This trial will compare two protocols for surgery patients: the Standard ASA NPO Protocol and the Liberal Feeding Protocol. Research has shown that using an ultrasound on the stomach effectively checks its contents before surgery. Studies have found that it quickly and accurately assesses the amount of food or liquid present. This information helps doctors determine if patients might face issues like aspiration. The ultrasound is particularly effective at identifying patients who haven't fully digested their last meal. Overall, using a stomach ultrasound reliably enhances surgical safety by assessing stomach contents.678910
Who Is on the Research Team?
Laura M Chiang, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 in the ICU who need general anesthesia or sedation and already have a cuffed breathing tube in place. It's not for those with upper GI tract issues, history of gastric perforation, without a proper breathing tube, or women past their first trimester of pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients undergo gastric ultrasound to quantify gastric residual volumes and compare NPO protocols
Follow-up
Participants are monitored for peri-operative aspiration events and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Gastric Ultrasound
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor